Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based discovery of nonopioid analgesics acting through the α 2A -adrenergic receptor
Elissa A. Fink, Jun Xu, Harald Hübner, et al.
Science (2022) Vol. 377, Iss. 6614
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Modeling the expansion of virtual screening libraries
Jiankun Lyu, John J. Irwin, Brian K. Shoichet
Nature Chemical Biology (2023) Vol. 19, Iss. 6, pp. 712-718
Open Access | Times Cited: 110
Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
Arash Sadri
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 12651-12677
Closed Access | Times Cited: 61
The Art and Science of Molecular Docking
Joseph M. Paggi, Ayush Pandit, Ron O. Dror
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 389-410
Closed Access | Times Cited: 61
AlphaFold2 structures guide prospective ligand discovery
Jiankun Lyu, Nicholas J. Kapolka, Ryan H. Gumpper, et al.
Science (2024) Vol. 384, Iss. 6702
Closed Access | Times Cited: 47
Tandem catalysis enables chlorine-containing waste as chlorination reagents
Mingyang Liu, Xinbang Wu, Paul J. Dyson
Nature Chemistry (2024) Vol. 16, Iss. 5, pp. 700-708
Open Access | Times Cited: 17
Computational drug development for membrane protein targets
Haijian Li, Xiaolin Sun, Wenqiang Cui, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 2, pp. 229-242
Closed Access | Times Cited: 16
A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years
Hui Zhu, Yulin Zhang, Wěi Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15961-15961
Open Access | Times Cited: 41
The structure, function, and pharmacology of MRGPRs
Can Cao, Bryan L. Roth
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 4, pp. 237-251
Open Access | Times Cited: 24
Recent Developments in Ultralarge and Structure-Based Virtual Screening Approaches
Christoph Gorgulla
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 229-258
Open Access | Times Cited: 23
Neuropathic pain; what we know and what we should do about it
Peter A. Smith
Frontiers in Pain Research (2023) Vol. 4
Open Access | Times Cited: 23
Explore drug-like space with deep generative models
Jianmin Wang, Jiashun Mao, Meng Wang, et al.
Methods (2023) Vol. 210, pp. 52-59
Closed Access | Times Cited: 22
Molecular mechanism of fatty acid activation of FFAR1
Punita Kumari, Asuka Inoue, Karen Chapman, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 22
Open Access | Times Cited: 22
Large library docking for novel SARS‐CoV‐2 main protease non‐covalent and covalent inhibitors
Elissa A. Fink, Conner Bardine, Stefan Gahbauer, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 22
Structure-based discovery of CFTR potentiators and inhibitors
Fangyu Liu, Anat Levit, Jesper Levring, et al.
Cell (2024) Vol. 187, Iss. 14, pp. 3712-3725.e34
Open Access | Times Cited: 12
The impact of library size and scale of testing on virtual screening
Fangyu Liu, Olivier Mailhot, Isabella Glenn, et al.
Nature Chemical Biology (2025)
Open Access | Times Cited: 1
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor
Edin Muratspahić, Kristine Deibler, Jianming Han, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Keeping pace with the explosive growth of chemical libraries with structure‐based virtual screening
Jacqueline Kuan, Mariia Radaeva, Adeline Avenido, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 19
Advances in the discovery of new chemotypes through ultra-large library docking
Felix Potlitz, Andreas Link, Lukas Schulig
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 303-313
Closed Access | Times Cited: 16
VirtualFlow 2.0 - The Next Generation Drug Discovery Platform Enabling Adaptive Screens of 69 Billion Molecules
Christoph Gorgulla, AkshatKumar Nigam, Matt Koop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 16
AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1
Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo, et al.
Science Advances (2024) Vol. 10, Iss. 32
Open Access | Times Cited: 7
Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT2A receptor
Supriya A. Gaitonde, Charlotte Avet, Mario de la Fuente Revenga, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2753-2764
Open Access | Times Cited: 6
Large library docking identifies positive allosteric modulators of the calcium-sensing receptor
Fangyu Liu, Cheng-Guo Wu, Chia‐Ling Tu, et al.
Science (2024) Vol. 385, Iss. 6715
Closed Access | Times Cited: 6
Large-Scale Docking in the Cloud
Benjamin I. Tingle, John J. Irwin
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 9, pp. 2735-2741
Open Access | Times Cited: 14
Long-term optical imaging of the spinal cord in awake, behaving animals
Biafra Ahanonu, Andrew Crowther, Artur Kania, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
Docking for EP4R antagonists active against inflammatory pain
Stefan Gahbauer, Chelsea DeLeon, João Braz, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top